Kevin_in_GA
4,599 posts
msg #80887
- Ignore Kevin_in_GA |
10/9/2009 12:36:02 PM
ACOR getting decimated today. Bad news on their FDA aproval for their key MS drug. Down 22% right now.
Ouch.
|
Kevin_in_GA
4,599 posts
msg #80888
- Ignore Kevin_in_GA
modified |
10/9/2009 12:43:43 PM
Confirmed BUY for yesterday - CGEN
Confirmed buy for today - ELGX (assuming nothing bad happens in the next three hours or so)
Awaiting confirmation from today - MR (assuming nothing GOOD happens in the next 3 hrs or so!)
|
Kevin_in_GA
4,599 posts
msg #80932
- Ignore Kevin_in_GA |
10/9/2009 9:45:32 PM
Except for ACOR, the portfolio did quite well today. While there are additional stocks that could also be added, they seemed to do well also. Not a bad week.
LINC is pretty close to tripping the 20% profit stop. One more good day might due it.
|
gabestogie
79 posts
msg #81005
- Ignore gabestogie |
10/13/2009 8:53:15 AM
Kevin:
Hoping to see LINC hit the profit point today.
Gabe
|
Kevin_in_GA
4,599 posts
msg #81008
- Ignore Kevin_in_GA |
10/13/2009 9:18:21 AM
Me too. Thought it might make it yesterday around 11 AM when it was at 23.79 (it only needs to go to 23.88 to trip the profit stop).
|
Kevin_in_GA
4,599 posts
msg #81009
- Ignore Kevin_in_GA
modified |
10/13/2009 9:19:28 AM
|
Kevin_in_GA
4,599 posts
msg #81039
- Ignore Kevin_in_GA |
10/13/2009 7:01:24 PM
|
Kevin_in_GA
4,599 posts
msg #81040
- Ignore Kevin_in_GA |
10/13/2009 7:04:52 PM
STAR, which was sold at a 20% profit (for $25.25 about a month ago) was just acquired for $35 a share.
It had been pinging against the upper BB for a couple of days already. Still a good trade, just a little early on the exit.
DL had a good day, up +9.6%. Still trading at -10% from my entry, but improvement is always welcome!
|
Kevin_in_GA
4,599 posts
msg #81057
- Ignore Kevin_in_GA |
10/14/2009 10:39:25 AM
7:28AM Acorda Therapeutics stock trading halted today; FDA Advisory Committee to review Fampridine-SR for improvement of walking ability in people with multiple sclerosis (ACOR) 16.74 : The co announces that NASDAQ has halted trading of Acorda common stock. The FDA Peripheral and Central Nervous System Drugs Advisory Committee meets today to review and discuss Acorda's New Drug Application (NDA) for Fampridine-SR for improvement of walking ability in people with multiple sclerosis (MS).
WOW.
|
gabestogie
79 posts
msg #81063
- Ignore gabestogie |
10/14/2009 12:10:11 PM
Kevin:
Sounds great
Gabe
|